Albuminuria by diabetes mellitus: Marker and motor of diabetic nephropathy and vascular complications

被引：0

作者：

Hunger-Dathe W. ^{[1
,2
]}

Wolf G. ^{[1
]}

机构：

[1] Klinik für Innere Medizin III, Klinikum, Friedrich-Schiller-Universität, Jena

[2] Klinik für Innere Medizin III, Klinikum, Friedrich-Schiller-Universität

来源：

Der Diabetologe | 2006年 / 2卷 / 5期

关键词：

Cardiovascular morbidity; Diabetic nephropathy; Microalbuminuria; Myocardial infarct; Stroke;

D O I：

10.1007/s11428-006-0069-z

中图分类号：

学科分类号：

摘要：

Diabetic nephropathy requires intensive treatment as it is the main reason for the morbidity and mortality resulting from diabetes mellitus. Patients with diabetic nephropathy have a significantly higher mortality rate due to cardiovascular events such as myocardial infarct or stroke. Microalbuminuria is the earliest clinical sign of diabetic renal disease and is also a marker for increased cardiovascular morbidity and mortality. Thus, its early detection allows not only for effective secondary prevention of the progression of diabetic nephropathy, but is also an indication for the implementation of an individually-tailored cardiovascular risk reduction management program. People with diabetes mellitus are high risk patients who need intensive monitoring and intensive supportive therapy. © Springer Medizin Verlag 2006.

引用

页码：400 / 409

页数：9

共 33 条

[11]

Kramer H.J., Nguyen Q.D., Curhan G., Hsu C.Y., Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus, JAMA, 289, pp. 3273-3277, (2003)

[12]

Leitao C.B., Canani L.H., Polson P.B., Et al., Urinary albumin excretion rate is associated with increased ambulatory blood pressure in normoalbuminuric type 2 diabetic patients, Diabetes Care, 28, pp. 1724-1729, (2005)

[13]

Liese A.D., Hense H.W., Doring A., Et al., Micro-albuminuria, central adiposity and hypertension in the non-diabetic urban population of the MONICA Augsburg survey 1994/95, J Hum Hypertens, 15, pp. 799-804, (2001)

[14]

Ohkubo Y., Kishikawa H., Araki E., Et al., Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study, Diabetes Res Clin Pract, 28, pp. 103-117, (1995)

[15]

Olsen S., Mogensen C.E., How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature, Diabetologia, 39, pp. 1638-1645, (1996)

[16]

Parving H.H., Lehnert H., Brochner-Mortensen J., Et al., The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes, N Engl J Med, 345, pp. 870-878, (2001)

[17]

Patel U.D., Young E.W., Ojo A.O., Hayward R.A., CKD progression and mortality among older patients with diabetes, Am J Kidney Dis, 46, pp. 406-414, (2005)

[18]

Rossing K., Schjoedt K.J., Smidt U.M., Et al., Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: A randomized, double-masked, cross-over study, Diabetes Care, 28, pp. 2106-2112, (2005)

[19]

Ruggenenti P., Fassi A., Ilieva A.P., Et al., Preventing microalbuminuria in type 2 diabetes, N Engl J Med, 351, pp. 1941-1951, (2004)

[20]

Sawicki P.T., Stabilization of glomerular filtration rate over 2 years in patients with diabetic nephropathy under intensified therapy regimens, Nephrol Dial Transplant, 12, pp. 1890-1899, (1997)

← 1 2 3 4 →